Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006800HBVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30084720HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063823HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063824HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063825HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20060150HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20059200HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20018080HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TCGA Plot Options
Drug Information
GeneGLRA1
DrugBank IDDB09130
Drug NameCopper
Target IDBE0000433
UniProt IDP23415
Regulation Type
PubMed IDs16842826
CitationsChen Z, Dillon GH, Huang R: Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors. Neuropharmacology. 2006 Sep;51(4):701-8. Epub 2006 Jul 12.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Cu]
Pathways
PharmGKBPA449114
ChEMBL